Pharmacia Drug Patent Portfolio

Pharmacia owns 2 orange book drugs protected by 9 US patents Given below is the list of Pharmacia's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6455574 Therapeutic combination 11 Aug, 2018 Expired
US5849535 Human growth hormone variants 25 Mar, 2017 Expired
US5969156 Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) 08 Jan, 2017 Expired
US5969156 Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) 08 Jul, 2016 Expired
US6057292 Method for inhibiting growth hormone action 21 Sep, 2015 Expired
US5686104 Stable oral CI-981 formulation and process of preparing same 11 May, 2015 Expired
US5686104 Stable oral CI-981 formulation and process of preparing same 11 Nov, 2014 Expired
US6126971 Stable oral CI-981 formulation and process for preparing same 19 Jul, 2013 Expired
US6126971 Stable oral CI-981 formulation and process for preparing same 19 Jan, 2013 Expired


Pharmacia's Family Patents


Family Patents



Pharmacia Drug List

Given below is the complete list of Pharmacia's drugs and the patents protecting them.


1. Caduet

Caduet is protected by 7 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6455574 Therapeutic combination 11 Aug, 2018
(6 years ago)
Expired
US5969156
(Pediatric)
Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) 08 Jan, 2017
(7 years ago)
Expired
US5969156 Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) 08 Jul, 2016
(8 years ago)
Expired
US5686104
(Pediatric)
Stable oral CI-981 formulation and process of preparing same 11 May, 2015
(9 years ago)
Expired
US5686104 Stable oral CI-981 formulation and process of preparing same 11 Nov, 2014
(9 years ago)
Expired
US6126971
(Pediatric)
Stable oral CI-981 formulation and process for preparing same 19 Jul, 2013
(11 years ago)
Expired
US6126971 Stable oral CI-981 formulation and process for preparing same 19 Jan, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Caduet's drug page


2. Somavert

Somavert is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5849535 Human growth hormone variants 25 Mar, 2017
(7 years ago)
Expired
US6057292 Method for inhibiting growth hormone action 21 Sep, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Somavert's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List